Spotting the Signs: Early Identification and Management of Schizophrenia
Desiree Matthews, PMHNP-BC
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Gil I. Wolfe MD, FAAN
Challenges in DMD: Understanding the Height Factor
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Ahmed Z. Obeidat, MD, PhD
High-Efficacy DMTs: Transforming MS Care
Long-Term Safety of DMTs: What We Know and What We Need to Know
Balancing Act: Immune Reconstitution vs Immune Suppression
From Pathology to Practice: The Role of Inflammation in MS Pathology
Fluid Biomarkers: Revolutionizing MS Diagnosis
Imaging Biomarkers: MS Progression in Focus
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Brain Health in MS: A Comprehensive Approach
PROs in MS: A New Era of Patient-Centric Care
Schizophrenia Care: Improving Social Cognition and Motivation
Michael Green, PhD
The Evolving gMG Treatment Landscape
Henry Kaminski, MD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.